Koyfin Home > Directory > Health Care > Acadia Pharmaceutica > EBITDA

Acadia Pharmaceutica EBITDA Chart (ACAD)

Acadia Pharmaceutica annual/quarterly EBITDA from 2010 to 2020. EBITDA stands for earnings before interest, taxes, depreciation and amortization. EBITDA is one indicator of a company's financial performance and is used as a proxy for the earning potential of a business, although doing so can have drawbacks. EBITDA strips out the cost of debt capital and its tax effects by adding back interest and taxes to earnings.
  • Acadia Pharmaceutica EBITDA for the quarter ending June 06, 2020 was $-43m a -3.43% increase of 1m year over year
  • Acadia Pharmaceutica EBITDA for the last 12 months ending June 06, 2020 was $-233m a -9.38% increase of 22m year over year
  • Acadia Pharmaceutica Annual EBITDA for 2019 was $-244m a -0.27% increase of 1m from 2018
  • Acadia Pharmaceutica Annual EBITDA for 2018 was $-244m a -18.52% increase of 45m from 2017
  • Acadia Pharmaceutica Annual EBITDA for 2017 was $-290m a 6.46% decrease of -19m from 2016
Other Income Statement Metrics:
  • Acadia Pharmaceutica Net Income for the quarter ending December 12, 2018 was $-65m a 17.10% decrease of -11m year over year
  • Acadia Pharmaceutica Total Revenue for the quarter ending September 09, 2018 was $58m a 25.29% increase of 15m year over year
View Chart On Koyfin

Quarterly ACAD EBITDA Data

06/2020$-43m
03/2020$-89m
12/2019$-56m
09/2019$-45m
06/2019$-56m
03/2019$-87m
12/2018$-66m
09/2018$-61m
06/2018$-63m
03/2018$-54m

Annual ACAD EBITDA Data

2019$-244m
2018$-244m
2017$-290m
2016$-271m
2015$-154m
2014$-93m
2013$-38m
2012$-21m
2011$-23m
2010$16m